---
figid: PMC3227927__onc0121007080001
figlink: /pmc/articles/PMC3227927/figure/F1/
number: F1
caption: 'Signaling pathways and effects of EGFR. Upon binding to one of multiple
  ligands, EGFR dimerizes with another member of the EGFR family, leading to the activation
  of the TK domain, phosphorylation of critical tyrosine residues in the EGFR intracellular
  domain, and activation of downstream signaling pathways, including MAPK, JAK-STAT,
  PLC, and PI3K–Akt. Collectively, EGFR signaling may lead to increased cell proliferation,
  decreased apoptosis, increased angiogenesis, increased invasion, and increased metastasis.
  As depicted above, multiple opportunities exist to inhibit EGFR signaling; for example,
  monoclonal antibodies (e.g., cetuximab and panitumumab) interact with the extracellular
  domain of EGFR preventing ligand-induced activation of the receptor, and small-molecule
  inhibitors (e.g., gefitinib, erlotinib, and lapatinib) block activation of the TK
  domain preventing induction of EGFR signaling pathways. Specific EGFR mutations
  may lead to constitutive activation of EGFR regardless of ligand binding and/or
  resistance of EGFR to the effects of TK inhibitors. Independent of receptor status,
  EGFR downstream signaling may become aberrantly activated; for example, mutant Ras
  may lead to constitutive activation of the MAPK pathway or mutation/loss of PTEN
  may lead to loss of negative regulation of the PI3K–Akt pathway.Abbreviations: DAG,
  diacylglycerol; EGFR, epidermal growth factor receptor; IP3, inositol triphosphate;
  JAK, Janus kinase; MAPK, mitogen-activated protein kinase; MEK, MAPK/extracellular
  signal–related kinase kinase; PDK, 3-phosphoinositide-dependent protein kinase;
  PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol bisphosphate; PKC, protein
  kinase C; PLC, phospholipase C; PTEN, phosphatase and tensin homologue deleted on
  chromosome ten; STAT, signal transducer and activator of transcription; TGF, transforming
  growth factor; TK, tyrosine kinase.'
pmcid: PMC3227927
papertitle: Treatment of Unresectable and Metastatic Cutaneous Squamous Cell Carcinoma.
reftext: Lee D. Cranmer, et al. Oncologist. 2010 Dec;15(12):1320-1328.
pmc_ranked_result_index: '108744'
pathway_score: 0.9532404
filename: onc0121007080001.jpg
figtitle: Signaling pathways and effects of EGFR
year: '2010'
organisms:
- Homo sapiens
ndex: 7e29cfc3-dea9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3227927__onc0121007080001.html
  '@type': Dataset
  description: 'Signaling pathways and effects of EGFR. Upon binding to one of multiple
    ligands, EGFR dimerizes with another member of the EGFR family, leading to the
    activation of the TK domain, phosphorylation of critical tyrosine residues in
    the EGFR intracellular domain, and activation of downstream signaling pathways,
    including MAPK, JAK-STAT, PLC, and PI3K–Akt. Collectively, EGFR signaling may
    lead to increased cell proliferation, decreased apoptosis, increased angiogenesis,
    increased invasion, and increased metastasis. As depicted above, multiple opportunities
    exist to inhibit EGFR signaling; for example, monoclonal antibodies (e.g., cetuximab
    and panitumumab) interact with the extracellular domain of EGFR preventing ligand-induced
    activation of the receptor, and small-molecule inhibitors (e.g., gefitinib, erlotinib,
    and lapatinib) block activation of the TK domain preventing induction of EGFR
    signaling pathways. Specific EGFR mutations may lead to constitutive activation
    of EGFR regardless of ligand binding and/or resistance of EGFR to the effects
    of TK inhibitors. Independent of receptor status, EGFR downstream signaling may
    become aberrantly activated; for example, mutant Ras may lead to constitutive
    activation of the MAPK pathway or mutation/loss of PTEN may lead to loss of negative
    regulation of the PI3K–Akt pathway.Abbreviations: DAG, diacylglycerol; EGFR, epidermal
    growth factor receptor; IP3, inositol triphosphate; JAK, Janus kinase; MAPK, mitogen-activated
    protein kinase; MEK, MAPK/extracellular signal–related kinase kinase; PDK, 3-phosphoinositide-dependent
    protein kinase; PI3K, phosphoinositide 3-kinase; PIP2, phosphatidylinositol bisphosphate;
    PKC, protein kinase C; PLC, phospholipase C; PTEN, phosphatase and tensin homologue
    deleted on chromosome ten; STAT, signal transducer and activator of transcription;
    TGF, transforming growth factor; TK, tyrosine kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K2
  - PDK1
  - PDK2
  - NRAS
  - MAPK9
  - KRAS
  - MAPK12
  - MAP2K1
  - MAPK10
  - BRAF
  - HRAS
  - EGF
  - RAF1
  - PDK3
  - MAPK3
  - MAPK13
  - STAT1
  - MAPK1
  - PIK3CG
  - PLCE1
  - MAPK11
  - PIK3CD
  - EGFR
  - PDK4
  - PIK3R3
  - PLCB2
  - MAPK14
  - PLCD4
  - PLCZ1
  - MAPK8
  - PTEN
  - ARAF
  - STAT6
  - AKT3
  - AKT1
  - AKT2
  - STAT2
  - STAT3
  - PIK3R6
  - TYK2
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - STAT5A
  - STAT5B
  - PLCB1
  - JAK2
  - TGFA
  - STAT4
  - JAK1
  - PRKCG
  - JAK3
  - PRKCZ
  - PLCG2
  - PIK3R5
  - PRKCH
  - PLCB4
  - PLCD3
  - PRKCE
  - HBEGF
  - PRKCD
  - PLCD1
  - PRKCI
  - PLCG1
  - PRKCB
  - PRKCQ
  - PRKD3
  - PRKCA
  - PLCB3
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: Ras-
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: Ras-
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras-
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: TGF-a
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: HB-EGF
  symbol: HBEGF
  source: hgnc_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
chemicals:
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC3227927__F1
redirect_from: /figures/PMC3227927__F1
figtype: Figure
---
